Deutsche Märkte öffnen in 2 Stunden 20 Minuten

Repligen Corporation (RGEN)

NasdaqGS - NasdaqGS Echtzeitpreis. Währung in USD
Zur Watchlist hinzufügen
158,16-0,62 (-0,39%)
Börsenschluss: 04:00PM EDT
161,23 +3,07 (+1,94%)
Nachbörse: 04:42PM EDT

Repligen Corporation

Building 1
Suite 100 41 Seyon Street
Waltham, MA 02453
United States
781 250 0111
https://www.repligen.com

Sektor(en)Healthcare
BrancheMedical Instruments & Supplies
Vollzeitmitarbeiter1.783

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Anthony J. HuntCEO & Director885kN/A1964
Mr. Olivier LoeillotPresident & Chief Commercial Officer1,49MN/A1970
Mr. Jason K. GarlandCFO & Chief Compliance Officer282,99kN/A1974
Mr. James R. BylundChief Operating Officer472,18kN/A1964
Ms. Christine GebskiSenior Vice President of Filtration & Chromatography396,09kN/A1968
Mr. Ralf KuriyelSenior Vice President of Research & Development401,74kN/A1958
Mr. Keith Lee RobinsonChief Information OfficerN/AN/AN/A
Ms. Sondra S. NewmanGlobal Head of Investor RelationsN/AN/AN/A
Ms. Kimberly A. CornwellGeneral Counsel & Global Head of LegalN/AN/AN/A
Mr. Neil WhitfieldVP & Global Head of SalesN/AN/AN/A
Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Corporate Governance

Repligen Corporations ISS Governance QualityScore, Stand 1. Mai 2024, lautet 2. Die grundlegenden Scores sind Audit: 8, Vorstand: 3, Shareholderrechte: 1, Kompensation: 4.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.